| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1057 |
| 1 | ADALIMUMAB | 1017 |
| 2 | RITUXIMAB | 987 |
| 3 | METHOTREXATE | 965 |
| 4 | LEFLUNOMIDE | 964 |
| 5 | TOCILIZUMAB | 964 |
| 6 | PREDNISONE | 909 |
| 7 | SULFASALAZINE | 897 |
| 8 | DICLOFENAC SODIUM | 870 |
| 9 | DICLOFENAC | 855 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAFFEINE CITRATE | 270 | 0.1157 |
| 1 | NEOMYCIN OINTMENT | 169 | 0.0689 |
| 2 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 43 | 0.0653 |
| 3 | HYDROCORTISONE SODIUM SUCCINATE | 247 | 0.0619 |
| 4 | TRIPROLIDINE HYDROCHLORIDE | 12 | 0.0615 |
| 5 | HYDROCORTISONE BUTYRATE | 116 | 0.0587 |
| 6 | DICLOFENAC POTASSIUM | 516 | 0.0467 |
| 7 | PSEUDOEPHEDRINE HCL | 501 | 0.0458 |
| 8 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 14 | 0.0456 |
| 9 | DESOXIMETASONE | 782 | 0.0406 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1048 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1035 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1004 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 989 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 988 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 965 |
| 6 | Antirheumatic Agent [EPC] | 964 |
| 7 | Aminosalicylate [EPC] | 931 |
| 8 | Vitamin C [EPC] | 865 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 854 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 152 | 0.0820 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 176 | 0.0202 |
| 2 | Provitamin D2 Compound [EPC] | 509 | 0.0171 |
| 3 | Aminosalicylate [EPC] | 931 | 0.0092 |
| 4 | Antirheumatic Agent [EPC] | 964 | 0.0091 |
| 5 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 989 | 0.0071 |
| 7 | Interleukin-12 Antagonist [EPC] | 735 | 0.0071 |
| 8 | Interleukin-23 Antagonist [EPC] | 735 | 0.0070 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 854 | 0.0061 |